hepat
e
viru
hev
genom
singlestrand
positivesens
rna
encod
three
protein
includ
replicas
mechan
hev
replic
host
cell
unclear
cellular
factor
involv
step
identifi
far
use
brefeldin
bfa
block
activ
cellular
arf
guanin
nucleotid
exchang
factor
play
major
role
reshuffl
cellular
membran
show
bfa
inhibit
hev
replic
dosedepend
manner
use
sirna
golgicid
identifi
host
factor
critic
involv
hev
replic
experi
use
cell
express
mutat
catalyt
domain
overexpress
wild
type
bfaresist
mutant
rescu
hev
replic
bfatreat
cell
confirm
bfasensit
factor
requir
hev
replic
demonstr
like
requir
activ
hev
replic
complex
howev
colocalis
protein
subcellular
distribut
unmodifi
upon
infect
overexpress
viral
protein
indic
like
recruit
replic
site
togeth
result
suggest
hev
replic
involv
mechan
industrialis
countri
common
genotyp
caus
hev
infect
importantli
due
evolut
toward
chronic
immunocompromis
infect
patient
hev
transmiss
blood
transfus
resist
infect
patient
ribavirin
complic
patient
preexist
liver
diseas
hev
infect
consid
emerg
problem
industrialis
countri
say
vercout
abdelwahab
vercauteren
meuleman
hev
classifi
sole
member
orthohepeviru
genu
within
hepevirida
famili
smith
et
al
quasienvelop
viru
contain
linear
singlestrand
positivesens
rna
genom
encod
three
open
read
frame
orf
name
tam
et
al
largest
gene
encod
nonstructur
polyprotein
protein
contain
sever
function
domain
essenti
viral
replic
koonin
et
al
function
domain
includ
methyltransferas
met
papainlik
cystein
proteas
rna
helicas
hel
rnadepend
rna
polymeras
review
debe
et
al
date
clear
evid
protein
process
proteas
antibodi
robustli
recognis
protein
avail
encod
viral
capsid
protein
involv
particl
assembl
bind
host
cell
elicit
neutralis
antibodi
recent
demonstr
lifecycl
hev
produc
three
form
capsid
protein
infectiousintracellular
glycosyl
cleav
protein
associ
infecti
particl
wherea
protein
massiv
produc
glycoprotein
associ
infecti
particl
major
antigen
present
hevinfect
patient
sera
montpelli
et
al
encod
small
multifunct
phosphoprotein
involv
virion
morphogenesi
egress
review
holla
ahmad
ahmad
jameel
due
difficulti
effici
propag
hev
cell
cultur
numer
pathway
process
hev
lifecycl
remain
elucid
notabl
mechan
lead
hev
replic
particularli
poorli
understood
howev
shown
protein
might
membraneassoci
localis
endoplasm
reticulumgolgi
intermedi
compart
ergic
suggest
hev
replic
might
occur
within
earli
secretori
pathway
spuul
ahola
plusstrand
rna
viru
replic
occur
close
associ
host
cell
membran
infect
cell
cellular
viral
factor
cooper
gener
particular
structur
resembl
organel
name
viral
replic
factori
compartmentalis
allow
coordin
differ
step
replic
cycl
highli
effici
rna
replic
protect
viral
genom
cell
defenc
mechan
note
number
virus
viral
bud
site
locat
near
replic
factori
indic
spatial
coordin
replic
viral
assembl
step
induc
massiv
membran
rearrang
virus
use
cellular
factor
activ
membran
exploit
cellular
pathway
involv
membran
homeostasi
review
paul
particular
virus
divert
compon
cellular
secretori
pathway
inde
shown
laboratori
guanin
nucleotideexchang
factor
golgi
brefeldin
bfa
resist
factor
necessari
hepat
c
viru
hcv
replic
farhat
et
al
goueslain
et
al
also
identifi
cellular
factor
essenti
replic
number
virus
picornavirus
coronavirus
belov
feng
nikov
jackson
ehrenfeld
lank
et
al
van
der
linden
van
der
schaar
lank
neyt
van
kuppeveld
verheij
et
al
investig
hev
replic
mechan
use
bfa
fungal
metabolit
inhibit
activ
arf
protein
small
gprotein
regul
cellular
secretori
pathway
inact
cytoplasm
gdpbound
form
arf
protein
upon
nucleotid
exchang
gtp
undergo
conform
chang
allow
arfgtp
protein
bind
membran
activ
gtpbound
form
arf
protein
essenti
format
secretori
vesicl
actin
remodel
phospholipid
metabol
recruit
membran
effector
mediat
process
bfa
block
arf
activ
inhibit
subset
guanin
nucleotid
exchang
factor
gef
regul
convers
arfgdp
arfgtp
human
cell
bfa
inhibit
function
three
known
arf
gef
stabilis
normal
transient
complex
form
gef
arfgdp
demonstr
bfa
inhibit
hev
replic
identifi
bfasensit
gef
requir
hev
replic
order
investig
role
cellular
membran
hev
infect
use
bfa
block
sever
membran
traffick
pathway
caus
major
membran
rearrang
host
cell
klausner
donaldson
lippincottschwartz
gaussia
luciferas
gluc
encod
subgenom
replicon
construct
deriv
hev
strain
modifi
produc
subgenom
replicon
sp
gluc
replicon
first
amino
acid
match
signal
peptid
gaussia
luciferas
delet
block
secret
luciferas
context
amount
intracellular
gluc
proport
viral
rna
synthesi
consequ
hev
replic
addit
system
allow
replic
monitor
independ
protein
secret
block
bfa
cell
electropor
vitrotranscrib
sp
gluc
rna
luciferas
activ
measur
hr
postelectropor
pe
time
point
valu
present
fold
increas
compar
luciferas
activ
measur
hr
pe
shown
figur
level
sp
gluc
steadili
increas
time
reach
fold
increas
time
hr
pe
indic
sp
gluc
replicon
effici
replic
cell
use
tool
studi
hev
replic
step
sp
glucelectropor
figur
indic
bfa
inhibitor
hev
replic
next
verifi
decreas
hev
replic
due
toxic
effect
bfa
treatment
perform
viabil
assay
cell
treat
hr
bfa
shown
figur
although
weak
toxic
observ
concentr
hev
replic
reduc
log
signific
toxic
effect
indic
inhibitori
effect
bfa
hev
replic
due
cell
toxic
order
confirm
inhibitori
effect
bfa
hev
replic
anoth
cell
line
next
analys
bfa
activ
hev
replic
cell
deriv
cell
clone
highli
replic
hev
genom
montpelli
et
al
figur
sp
gluc
shown
figur
bfa
effici
inhibit
sp
gluc
replic
transfect
cell
indic
inhibitori
effect
bfa
hev
replic
cell
line
depend
also
analys
antivir
activ
bfa
cell
transfect
firefli
luciferas
fluc
encod
subgenom
replicon
figur
bfa
strongli
inhibit
replic
indic
bfa
inhibitori
effect
hev
replic
genotyp
depend
lastli
perform
experi
fulllength
infecti
clone
shukla
et
al
cell
electropor
fulllength
strain
rna
bfa
ad
hr
hr
posttransfect
cell
fix
analys
immunofluoresc
capsid
protein
antibodi
shown
figur
treatment
bfa
led
signific
valu
present
percentag
replic
compar
cell
treat
dimethyl
sulfoxid
dmso
cell
electropor
sp
gluc
rna
e
cell
electropor
rna
f
treat
hr
brefeldin
indic
concentr
luciferas
activ
measur
hr
pe
valu
present
percentag
replic
compar
cell
treat
dmso
g
cell
electropor
fulllength
infecti
strain
rna
treat
brefeldin
hr
indic
concentr
hr
posttransfect
cell
fix
analys
immunofluoresc
capsid
protein
antibodi
valu
adjust
infect
nontreat
cell
mock
result
present
mean
standard
deviat
three
independ
experi
mean
pvalu
respect
decreas
cell
indic
bfa
inhibit
hev
lifecycl
altogeth
result
demonstr
bfa
inhibit
hev
replic
like
block
cellular
factor
necessari
step
viral
lifecycl
like
requir
hev
replic
bfa
inhibit
sever
cellular
membran
traffick
pathway
primarili
inhibit
major
cellular
target
member
arf
gef
famili
among
member
arf
gef
famili
human
cell
three
inhibit
bfa
souzaschorey
chavrier
gillingham
munro
check
three
bfasensit
gef
requir
hev
replic
analys
effect
deplet
hev
replic
figur
howev
silenc
toxic
experiment
condit
due
slow
kinet
hev
replic
requir
long
deplet
time
altern
use
golgicid
gca
specif
inhibit
effect
et
al
cell
transfect
sirna
pool
target
nontarget
sirna
pool
figur
two
day
posttransfect
deplet
cell
electropor
sp
gluc
replicon
luciferas
activ
measur
hr
pe
describ
previous
shown
figur
deplet
togeth
result
signific
decreas
hev
replic
level
contrast
sp
glucelectropor
cell
treat
gca
specif
target
hev
replic
level
strongli
inhibit
figur
without
signific
toxic
figur
altogeth
result
suggest
like
bfaand
gcasensit
factor
requir
hev
replic
previou
studi
assess
role
hcv
replic
isol
bfaresist
cell
clone
deriv
hepatoma
cell
line
farhat
et
al
cell
line
resist
bfa
abl
support
hcv
replic
presenc
time
bfa
parent
cell
line
resist
due
point
mutat
catalyt
domain
known
impair
bind
bfa
farhat
et
al
order
confirm
bfa
inhibit
hev
replic
relat
effect
drug
transfect
sp
gluc
replicon
parent
cell
figur
togeth
result
support
conclus
bfasensit
factor
requir
hev
replic
inhibit
hev
replic
due
direct
effect
viru
figur
brefeldin
asensit
factor
requir
hepat
e
viru
replic
cell
transfect
sirna
pool
target
nontarget
sirna
pool
two
day
posttransfect
silenc
control
western
blot
antibodi
direct
antibodi
direct
tubulin
use
control
protein
load
b
two
day
posttransfect
deplet
cell
electropor
sp
gluc
replicon
luciferas
activ
measur
hr
pe
valu
present
percentag
replic
compar
cell
transfect
nontarget
sirna
pool
c
hepat
e
sp
glucelectropor
cell
treat
hr
golgicid
indic
concentr
luciferas
activ
c
viabil
quantifi
hr
pe
valu
present
percentag
replic
compar
cell
treat
dimethyl
sulfoxid
result
b
c
present
mean
standard
deviat
three
independ
experi
mean
pvalu
express
wildtyp
bfaresist
mutant
rescu
hev
replic
bfatreat
cell
confirm
host
factor
sensit
bfa
requir
hev
replic
next
use
complement
assay
figur
inde
shown
overexpress
express
bfaresist
mutant
rescu
hcv
replic
bfa
inhibit
wherea
express
catalyt
inact
mutant
farhat
et
al
goueslain
et
al
jackson
casanova
niu
pfeifer
lippincottschwartz
jackson
therefor
transfect
cell
plasmid
express
yfpfuse
wildtyp
liang
zheng
bao
zhang
qin
et
al
van
der
linden
et
al
verheij
et
al
wang
du
jin
howev
shown
involv
format
polioviru
mous
hepat
coronaviru
hcv
replic
complex
rather
matur
activ
belov
et
al
goueslain
et
al
verheij
et
al
order
investig
involv
hev
replic
next
perform
timecours
experi
bfa
ad
hr
variou
time
point
hr
electropor
replic
level
measur
hr
pe
figur
strong
inhibit
hev
replic
bfa
observ
whatev
time
addit
drug
even
bfa
ad
hr
pe
indic
bfa
abl
inhibit
hev
replic
cell
replic
complex
alreadi
form
togeth
result
suggest
requir
activ
hev
replic
complex
assembl
demonstr
cellular
factor
requir
hev
replic
next
analys
subcellular
localis
hevrepl
cell
use
immunofluoresc
confoc
microscopi
figur
due
lack
tool
probe
protein
hevrepl
cell
lenggenhag
et
al
colocalis
studi
hev
replicas
could
perform
therefor
nontransfect
cell
cell
transfect
fulllength
infecti
clone
costain
antibodi
direct
capsid
protein
expect
nontransfect
cell
stain
observ
golgilik
perinuclear
structur
cytoplasm
small
dotlik
structur
figur
similar
intracellular
distribut
observ
hevrepl
cell
figur
indic
major
subcellular
localis
modifi
upon
hev
replic
therefor
like
recruit
stabli
maintain
hev
replic
complex
result
obtain
transfect
cell
data
shown
altern
approach
determin
whether
recruit
replic
site
analys
subcellular
localis
cell
overexpress
nonstructur
polyprotein
combin
structur
protein
figur
protein
detect
three
differ
antibodi
direct
either
met
hel
pol
domain
observ
differ
localis
upon
express
viral
protein
addit
costain
regardless
antibodi
use
strengthen
hypothesi
probabl
recruit
hev
replic
site
due
difficulti
amplifi
hev
cell
cultur
absenc
tool
analys
hev
nonstructur
protein
mechan
lead
hev
replic
particularli
poorli
understood
site
rna
replic
within
host
cell
identifi
yet
howev
use
vector
system
show
nonstructur
polyprotein
might
membraneassoci
localis
ergic
suggest
hev
replic
might
occur
within
earli
secretori
pathway
et
al
studi
show
activ
hev
replic
complex
strongli
depend
gef
regul
activ
arf
small
gprotein
turn
key
regul
cellular
secretori
pathway
demonstr
bfa
gca
specif
inhibitor
inhibit
hev
replic
bfasensit
cellular
factor
requir
hev
replic
arf
protein
regul
copico
vesicl
transport
souzaschorey
chavrier
also
particip
golgi
morphogenesi
lipid
droplet
metabol
jackson
bouvet
addit
hijack
sever
positivestrand
rna
virus
includ
picornavirida
coronavirida
flavivirida
member
replic
belov
et
al
carpp
et
al
goueslain
et
al
lank
et
al
liang
et
al
qin
et
al
van
der
linden
et
al
verheij
et
al
wang
et
al
instanc
shown
interact
polioviru
coxsackieviru
nonstructur
protein
wessel
et
al
wessel
et
al
overexpress
rescu
enteroviru
replic
cell
treat
bfa
wherea
silenc
strongli
inhibit
viral
replic
belov
et
al
lank
et
al
precis
role
enteroviru
replic
clear
propos
arfactiv
function
would
necessari
enteroviru
replic
recruit
cellular
factor
support
replic
phosphatidylinositol
kinas
hsu
et
al
howev
recent
data
suggest
enteroviru
replic
requir
ntermin
region
protein
arfgef
activ
belov
kovtunovych
jackson
ehrenfeld
viktorova
nchoutmboub
fordsiltz
belov
contrast
activ
crucial
mous
hepat
coronaviru
rna
replic
verheij
et
al
also
host
factor
requir
hcv
replic
goueslain
et
al
contrast
enterovirus
interact
viral
protein
report
far
addit
shown
recent
role
hcv
replic
mediat
arfgef
activ
farhat
et
al
interestingli
shown
essenti
mediat
function
hcv
replic
yet
deplet
two
arf
protein
inhibit
secretori
pathway
instead
affect
lipid
metabol
farhat
et
al
studi
demonstr
essenti
function
hev
replic
experi
use
arf
protein
express
knockdown
mutant
catalyt
domain
farhat
et
al
necessari
defin
import
arfgef
activ
hev
replic
belov
et
al
erresid
reticulon
protein
tang
et
al
wherea
alphavirus
subvert
amphiphysin
localis
plasma
membran
membran
remodel
viral
rna
replic
neuvonen
et
al
mention
previous
essenti
replic
enterovirus
coronavirus
flavivirus
virus
induc
remodel
intracellular
membran
present
studi
demonstr
cellular
factor
requir
activ
hev
replic
complex
base
fact
virus
use
replic
induc
membran
rearrang
therefor
specul
hev
replic
might
depend
membran
reshuffl
studi
use
electron
microscopi
cell
highli
replic
hev
genom
thu
requir
test
hypothesi
order
determin
whether
recruit
protein
replic
complex
observ
polioviru
nonstructur
protein
wessel
et
al
wessel
et
al
analys
subcellular
distribut
howev
although
fulllength
protein
domain
nonstructur
protein
detect
antibodi
cell
transfect
vector
system
lenggenhag
et
al
et
al
antibodi
fail
detect
protein
hevrepl
cell
data
shown
lenggenhag
et
al
lack
tool
direct
prevent
us
analys
whether
recruit
replic
complex
hevrepl
cell
indirect
approach
first
analys
subcellular
distribut
hev
replic
nonrepl
cell
found
evid
chang
intracellular
localis
second
altern
approach
studi
subcellular
distribut
cell
overexpress
viral
replicas
found
intracellular
pattern
unaffect
viral
protein
express
addit
find
evid
colocalis
result
suggest
involv
hcv
replic
might
indirect
role
hev
replic
activ
effector
involv
hev
replic
howev
experi
costain
protein
hevrepl
cell
need
elucid
involv
hev
replic
develop
tool
allow
probe
protein
hevrepl
cell
thu
essenti
characteris
mechan
hev
replic
involv
nakabayashi
taketa
miyano
yaman
sato
blight
mckeat
rice
farhat
et
al
montpelli
et
al
rabbit
antihev
polyclon
antibodi
met
hel
polymeras
domain
kindli
provid
tero
ahola
univers
helsinki
finland
et
al
mous
antihev
mab
antibodi
registri
millipor
mous
antigfp
mab
roch
rabbit
antibodi
bethyl
laboratori
mous
antibodi
registri
bd
bioscienc
mous
tubulin
sigma
secondari
antibodi
jackson
immunoresearch
subconflu
cell
cultur
grown
plate
incub
bfa
gca
dmso
hr
incub
time
sofosbuvir
kept
cultur
hr
base
viabil
assay
celltit
aqueou
nonradioact
cell
prolifer
assay
promega
conduct
recommend
manufactur
plasmid
express
cell
cultur
adapt
kernow
strain
genbank
access
number
replicon
express
gaussia
luciferas
gene
provid
u
emerson
shukla
et
al
replicon
construct
use
gener
new
replicon
construct
sp
gluc
first
amino
acid
match
signal
peptid
gaussia
luciferas
delet
block
luciferas
secret
fusion
polymeras
chain
reaction
done
extern
primer
intern
primer
strain
replicon
express
firefli
luciferas
describ
previous
pudupakam
et
al
kindli
provid
xj
meng
virginia
polytechn
institut
state
univers
blacksburg
va
cap
rna
transcript
gener
mmessag
kit
ambion
deliv
cell
electropor
use
gene
pulser
apparatu
biorad
plasmid
express
yellow
fluoresc
protein
yfp
yfptag
yfptag
yfptag
describ
previous
goueslain
et
al
niu
et
al
well
seed
cell
electropor
sp
gluc
rna
drug
bfa
gca
sofosbuvir
ad
hr
pe
kept
h
hr
pe
cell
lyse
buffer
provid
manufactur
promega
gaussia
firefli
luciferas
activ
determin
correspond
luciferas
assay
system
promega
use
tristar
luminomet
berthold
luciferas
activ
hr
pe
use
determin
electropor
effici
rna
interfer
experi
carri
pool
four
differ
synthet
doublestrand
sirna
target
ontarget
plu
smart
pool
reagent
dharmacon
control
use
studi
ontarget
plu
nontarget
sirna
sirna
transfect
lipofectamin
rnai
max
life
technolog
ad
ml
dpb
incub
min
sixwel
plate
sirna
spot
centr
well
case
doubl
sirna
transfect
sirna
use
dilut
transfect
reagent
ad
sirna
mixtur
incub
min
room
temperatur
end
incub
freshli
trypsinis
cell
volum
ml
cultur
medium
ad
transfect
mix
cell
return
two
day
posttransfect
cell
trypsinis
sp
gluc
replicon
rna
electropor
describ
previous
cell
seed
sixwel
plate
transfect
plasmid
express
yfpfuse
wild
type
yfpfuse
mutant
yfp
protein
transit
reagent
follow
instruct
manufactur
miru
two
day
posttransfect
express
protein
control
western
blot
fluoresc
microscopi
cell
electropor
infecti
fulllength
rna
cultur
hr
presenc
bfa
ngml
hr
pe
cell
fix
methanol
stain
antibodi
transfect
protein
yfp
cell
valu
adjust
cell
cultur
presenc
dmso
transfect
cell
rins
three
time
cold
pb
lyse
min
buffer
contain
mm
triscl
mm
nacl
mm
ethylenediaminetetraacet
acid
tritonx
sodium
dodecyl
sulfat
ph
mm
phenylmethylsulfonyl
fluorid
proteas
inhibitor
cocktail
complet
insolubl
materi
remov
centrifug
protein
resolv
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
transfer
onto
nitrocellulos
membran
hybondecl
amersham
use
transblot
apparatu
biorad
protein
interest
reveal
specif
primari
antibodi
follow
speciesspecif
secondari
antibodi
conjug
peroxidas
protein
visualis
use
enhanc
chemiluminesc
ecl
plu
ge
healthcar
signal
record
use
la
apparatu
fujifilm
indirect
immunofluoresc
label
perform
previous
describ
rouill
et
al
nuclei
stain
cell
transfect
fulllength
rna
stain
mous
mab
posit
cell
count
condit
confoc
microscopi
analys
cell
transfect
fulllength
rna
costain
antibodi
cell
transfect
combin
costain
met
hel
polymeras
domain
antibodi
